Articles

The Fed ‘s pivot has amplified speculative risk-taking, says this analyst

Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is likely to fail, as it set the most pessimistic target price forecast of any Wall Street bank on the Danish drugmaker.

Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.

“My husband jokes that he will never be able to retire because we do not own a home.”

Gavekal Research predicts more stock repurchases are coming, representing an additional tailwind for the current bull market.

Butler didn’t seem to have any concerns buying the home, known as the “steel house”, that was once ransacked by thieves.

The federal government’s primary car safety watchdog has delayed several rules that were meant to take effect for the 2026 model year.

Known as the “Magnificent Bullard Estate,” the picturesque property served as an escape from Hollywood for the action star.

Shares of U.K. pharmaceutical giant GSK rallied on Monday after it turned to an insider to become its next CEO.

U.S. stock-market futures were flat late Sunday, as investors wait and see whether there’ll be a government shutdown later this week.

Stocks are defying their typical weakness in September — but it isn’t October yet

“We plan to work another 20 years and we estimate $3-$4 million in 401(k) savings.”